Tocris/Thalidomide/0652/100/100 mg
克隆和表達
商品編號
0652/100
品牌
Tocris
公司
Bio-Techne Corporation
公司分類(lèi)
Ligases
Size
100 mg
商品信息
Description:
Binds cereblon, inhibiting ubiquitin ligase activity; alsoTNF-a synthesis inhibitor
Chemical Name:
N
-(2,6-dioxo-3-piperidinyl)phthalimide
Purity:
≥99% (HPLC)
BIOLOG
ical Activity
Technical Data
Solubility
Calculators
Datasheets
References
BIOLOG
ical Activity
Selective inhibitor of tumor necrosis factor
α
(TNF-
α
) synthesis. Also binds cereblon, inhibiting ubiquitin ligase activity. Teratogen, sedative-hypnotic with inherent anti-inflammatory properties.
Technical Data
M. Wt
258.23
Formula
C
13
H
10
N
2
O
4
Storage
Store at RT
Purity
≥99% (HPLC)
CAS Number
50-35-1
PubChem ID
5426
InChI Key
UEJJHQNACJXSKW-UHFFFAOYSA-N
Smiles
O=C1N(C2CCC(=O)NC2=O)C(=O)C2=C1C=CC=C2
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All
Tocris
products are intended for laboratory research use only.
Solubility Data
Solvent
Max Conc. mg/mL
Max Conc. mM
Solubility
DMSO
6.46
25
Preparing Stock Solutions
The following data is based on the
product
molecular weight
258.23
. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass
1 mg
5 mg
10 mg
1 mM
3.87 mL
19.36 mL
38.73 mL
5 mM
0.77 mL
3.87 mL
7.75 mL
10 mM
0.39 mL
1.94 mL
3.87 mL
50 mM
0.08 mL
0.39 mL
0.77 mL
Molarity Calculator
Molarity Calculator
Calculate the mass, volume, or concentration required for a solution.
Reconstitution Calculator
Reconstitution Calculator
Dilution Calculator
Dilution Calculator
Calculate the dilution required to prepare a stock solution.
Product Datasheets
Certificate of Analysis / Product Datasheet
Safety Datasheet
Select another language:
English
German
French
Spanish
View SDS
References
References are publications that support the products'
BIOLOG
ical activity.
Boireau
et al
(1997) Thalidomide reduces MPTP-induced decrease in striatal dopamine levels in mice. Neurosci.Lett.
234
123 PMID: 9364513
Kanbayashi
et al
(1996) Thalidomide, a hypnotic with immune modulating properties, increases cataplexy in canine narcolepsy. Neuroreport
7
1881 PMID: 8905685
Makonkawkeyoon
et al
(1993) Thalidomide inhibits the replication of human-immunodeficiency-virus type 1. Proc.Natl.Acad.Sci.U.S.A.
90
5974 PMID: 8327469
Zhang
et al
(2008) Thalidomide influences growth and vasculogenic mimicry channel formation in melanoma. J.Exp.Clin.Cancer Res.
27
60 PMID: 18983651
Sampaio
et al
(1991) Thalidomide selectively inhibits tumor necrosis factor α production by stimulated human monocytes. J.Exp.Med.
173
699 PMID: 1997652
Merck
Index
12
9390 PMID:
Ito
et al
(2010) Identification of a primary target of thalidomide teratogenicity. Science
327
1345 PMID: 20223979
Keywords: Thalidomide, supplier, TNF-α, TNF-alpha, synthesis, inhibitors, inhibits, Interleukins, Tumor, Necrosis, Factor-α, Factor-alpha, Cytokines, Signaling, Signalling, teratogen, anti-inflammatory, angiogenesis, cereblon, ubiquitin, E3, ligase, Cytokines, Antiangiogenics, Ubiquitin, E3, Ligases, Ubiquitin, E3, Ligases,
Tocris
Bioscience
產(chǎn)品貨號:784.8